Skip to content

Nifedipine versus Atosiban in the treatment of threatened preterm labour: APOSTEL III

Nifedipine versus Atosiban in the treatment of threatened preterm labour: APOSTEL III - APOSTEL III

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38113
Enrollment
500
Registered
2010-11-23
Start date
2011-07-06
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm delivery threatened preterm birth

Interventions

Nifedipine (dosage: first hour 20 mg followed by 4 dd 20 mg retard orally for 47 hours) versus Atosiban (dosage: bolus injection of 6,75 mg i.v. in 1 minute, followed by a 18 mg/hour for 3 hours fol

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women * 18 years old with a singleton pregnancy with a gestational age of 24-34 weeks in threatened preterm labour, as defined by: * Uterine contractions, at least 3 contractions per 30 minutes and a cervical length of * 10 mm ór * Uterine contractions, at least 3 contractions per 30 minutes and a cervical length of 11-30 mm ánd a positive Fibronectin test ór * Ruptured amniotic membranes

Exclusion criteria

Exclusion criteria: - Vaginal bleeding - Cerclage - Cervical dilatation > 30 mm - Previous treatment for preterm contractions - Hypertension / anti-hypertensive agent - Myocardial infarction (

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be a composite for poor neonatal outcome. This outcome will include chronic lung disease, periventricular leucomalacia > grade 1, intraventricular haemorrhage > grade 2, NEC > stage 1, proven sepsis and in-hospital death.

Secondary

MeasureTime frame
Secondary outcomes will be time to delivery, gestational age at delivery, number of days on ventilation support, number of days in NICU, total days of the baby alive outside the hospital counted from a gestational age of 37 weeks and maternal side effects.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)